Markus Lüngen

Author PubWeight™ 9.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 German diabetes management programs improve quality of care and curb costs. Health Aff (Millwood) 2010 2.47
2 Mental Disorders in People Affected by Thalidomide. Dtsch Arztebl Int 2017 2.01
3 Preliminary analysis of short-term financial implications of a prevention bonus program: first results from the German Statutory Health Insurance. Int J Public Health 2008 1.08
4 Financial incentives in the German Statutory Health Insurance: new findings, new questions. Health Policy 2010 1.06
5 [DRG in the context of current health policy]. Med Klin (Munich) 2003 0.88
6 Direct, indirect, and intangible costs after severe trauma up to occupational reintegration - an empirical analysis of 113 seriously injured patients. Psychosoc Med 2013 0.81
7 Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany. Pediatr Allergy Immunol 2012 0.81
8 Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation. Eur J Health Econ 2012 0.77
9 Correspondence (letter to the editor): Matching should take place before the start of the study. Dtsch Arztebl Int 2011 0.75
10 Substitution of theophylline slow-release formulations according to the rebate contracts in the German statutory health insurance. Arzneimittelforschung 2009 0.75
11 Direct non-medical and indirect costs for families with children with congenital cardiac defects in Germany: a survey from a university centre. Cardiol Young 2010 0.75